Marwa Al-Azzawi1, Joseph Misdraji2, Marie-Louise F van Velthuysen3, Jinru Shia4, Melissa W Taggart5, Rhonda K Yantiss6, Magali Svrcek7, Norman Carr8. 1. Department of Surgery, Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital, Basingstoke, UK azzawi91@hotmail.com. 2. Depatment of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA. 3. Department of Pathology, Erasmus Medical Centre, Rotterdam, The Netherlands. 4. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. 5. Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. 6. Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York city, New York, USA. 7. Department of Pathology, Hôpital Saint-Antoine, Paris, France. 8. Department of Pathology, Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital, Basingstoke, UK.
Authors: Blanca Rufián-Andujar; Francisca Valenzuela-Molina; Sebastián Rufián-Peña; Ángela Casado-Adam; Juan Manuel Sánchez-Hidalgo; Lidia Rodríguez-Ortiz; Francisco Javier Medina-Fernández; Cesar Díaz-López; Rosa Ortega-Salas; Ana Martínez-López; Javier Briceño-Delgado; Antonio Romero-Ruíz; Álvaro Arjona-Sánchez Journal: Ann Surg Oncol Date: 2021-01-20 Impact factor: 5.344